Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 1819794, 14 pages
http://dx.doi.org/10.1155/2016/1819794
Review Article

Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis

1Traditional Chinese Medicine Clinical Research Base for Hypertension, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. 42, Wenhua Xi Road, Jinan, Shandong 250011, China
2Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China

Received 21 February 2016; Revised 29 June 2016; Accepted 6 July 2016

Academic Editor: Giuseppe Caminiti

Copyright © 2016 Yu-Shuo Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Maron, J. A. Towbin, G. Thiene et al., “Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention,” Circulation, vol. 113, no. 14, pp. 1807–1816, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Pankuweit, C. Lüers, A. Richter, V. Ruppert, G. Gelbrich, and B. Maisch, “Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy,” European Journal of Clinical Investigation, vol. 45, no. 9, pp. 906–917, 2015. View at Publisher · View at Google Scholar
  3. R. F. Gillum, “Idiopathic cardiomyopathy in the United States, 1970–1982,” American Heart Journal, vol. 111, no. 4, pp. 752–755, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Guangyong, G. Hang, M. Xiangang et al., “Epidemiology and etiology of dilated cardiomyopathy,” Journal of Prevention and Control of Chronic Diseases in China, vol. 1, pp. 42–44, 2009. View at Google Scholar
  5. M. Komajda, J. P. Jais, F. Reeves et al., “Factors predicting mortality in idiopathic dilated cardiomyopathy,” European Heart Journal, vol. 11, no. 9, pp. 824–831, 1990. View at Google Scholar · View at Scopus
  6. Y. Matsumura, E. Hoshikawa-Nagai, T. Kubo et al., “Left ventricular reverse remodeling in long-term (>12 Years) survivors with idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 111, no. 1, pp. 106–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Redfield, B. J. Gersh, K. R. Bailey, D. J. Ballard, and R. J. Rodeheffer, “Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend,” Journal of the American College of Cardiology, vol. 22, no. 7, pp. 1921–1926, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Zhouyan, T. Qizhu, L. Fangfang, and W. Wen, “A systematic review of the effect of Astragalus Injection in the treatment of dilated cardiomyopathy,” Journal of Medical Research, vol. 11, pp. 70–72, 2011. View at Google Scholar
  9. Z. Xueli, C. Kuaile, Y. Jun, and T. Lili, “40 Patients with dilated cardiomyopathy treated Qiliqiangxin capsule,” Shaanxi Traditional Chinese Medicine, vol. 5, pp. 549–551, 2010. View at Google Scholar
  10. J. Qiulei, H. Yuanhui, S. Qingqiao et al., “Effectiveness and safety of Shen Fu Injection in the treatment of dilated cardiomyopathy,” Chinese Journal of Evidence Based Medicine, vol. 5, pp. 609–613, 2015. View at Google Scholar
  11. G. Duhai, D. Huiwen, H. Zhaozhan et al., “Clinical observation on treatment of 32 cases with dilated cardiomyopathy by Changpu Qidan Decoction,” Hebei Traditional Chinese Medicine, vol. 9, pp. 1326–1327, 2012. View at Google Scholar
  12. H. Zhaozhan, “Clinical study on the treatment of dilated cardiomyopathy by Changpu Qidan Decoction,” Hebei Traditional Chinese Medicine, vol. 7, pp. 983–985, 2014. View at Google Scholar
  13. L. Wenyu and L. Yuhong, “Curative effect observation on 45 cases of dilated cardiomyopathy with heart failure treated with Jian Xin Decoction,” Yunnan Journal of Traditional Chinese Medicine, vol. 4, pp. 24–25, 2009. View at Google Scholar
  14. L. Qing and H. Daoqing, “To observe the curative effect of Qifu Yangxin Decoction in the treatment of dilated cardiomyopathy,” Shanxi Traditional Chinese Medicine, vol. 10, pp. 1277–1278, 2013. View at Google Scholar
  15. Y. Yi, “Lingxie Qiangxin Decoction in treating 70 patients with yang deficiency and water deluge generic dilated cardiomyopathy,” Journal of Cardiovascular and Cerebrovascular Diseases, vol. 11, pp. 1311–1312, 2013. View at Google Scholar
  16. Z. Min, W. Lei, and W. Renping, “Clinical observation on treatment of 116 cases with dilated cardiomyopathy by Xinji Huoli Decoction,” Hebei traditional Chinese Medicine, vol. 9, pp. 954–955, 2008. View at Google Scholar
  17. W. Xinyu, L. Shu, G. Shaoyu et al., “Clinical observation on treatment of dilated cardiomyopathy by Xinlishen decoction,” New Traditional Chinese Medicine, no. 3, pp. 20–22, 2001. View at Google Scholar
  18. Y. Hongya and D. Yanjie, “Clinical observation of 35 cases of Zhigancao Decoction in patients with dilated cardiomyopathy,” Journal of Cardiovascular and Cerebrovascular Diseases, vol. 11, pp. 1269–1270, 2008. View at Google Scholar
  19. S. Lili and Z. Hui, “Clinical observation of traditional Chinese medicine combined with western medicine on 30 patients with dilated cardiomyopathy,” Traditional Chinese Medicine Information, vol. 1, pp. 25–26, 2005. View at Google Scholar
  20. F. Hui, W. Xiaodong, X. Xiaopeng, and C. Jing, “Clinical observation of traditional Chinese Medicine Combined with Western Medicine on 32 Patients with Dilated Cardiomyopathy,” Journal of Traditional Chinese Medicine, vol. 12, pp. 2328–2329, 2004. View at Google Scholar
  21. B. Rongqi, “Observation of traditional Chinese medicine combined with western medicine on 34 patients with dilated cardiomyopathy,” Journal of Practical Traditional Chinese Medicine, vol. 10, pp. 678–679, 2009. View at Google Scholar
  22. Y. Xi and C. Jianhua, “Clinical observation of traditional Chinese medicine combined with western medicine on 39 patients with dilated cardiomyopathy,” Gansu Traditional Chinese Medicine, vol. 5, pp. 15–16, 2006. View at Google Scholar
  23. W. Renping, D. Sushe, M. Fangfei et al., “Clinical observation of Traditional Chinese Medicine combined with western medicine on 45 patients with dilated cardiomyopathy,” Chinese Medical Journal, vol. 12, pp. 737–738, 2004. View at Google Scholar
  24. X. Shaohan, D. Bin, C. Yun et al., “Clinical observation of traditional Chinese medicine combined with western medicine on 46 patients with dilated cardiomyopathy,” Modern Medical and Health, vol. 18, pp. 2424–2425, 2005. View at Google Scholar
  25. Y. Yongxuan and Z. Bende, “Clinical observation on the treatment of refractory heart failure of dilated cardiomyopathy with integrated traditional Chinese and western medicine,” Integrated Traditional Chinese and Western Medicine Practical Clinical First Aid, vol. 5, pp. 12–13, 1997. View at Google Scholar
  26. C. Xuebin, W. Chaohong, Z. Yongcheng et al., “Combination of Traditional Chinese Medicine and western medicine in the treatment of dilated cardiomyopathy and heart failure: observation of 21 cases,” National Medical Forum, vol. 1, article 36, 1995. View at Google Scholar
  27. C. Wanqiang, X. Chengxiang, M. Hui et al., “Therapeutic effect of combination of traditional Chinese and western medicine in treatment of dilated cardiomyopathy,” Northwest National Defence Medical Journal, vol. 4, pp. 286–287, 1999. View at Google Scholar
  28. D. Huiwen, G. Duhai, Y. Jie et al., “Clinical study on the effect of Changpu Qidan Decoction on cardiac function in patients with dilated cardiomyopathy,” Sichuan Traditional Chinese Medicine, no. 1, pp. 82–84, 2013. View at Google Scholar
  29. H. Wuyi, “Clinical observation on 23 cases of dilated cardiomyopathy treated with combination of traditional Chinese and western medicine,” Chinese Folk Medicine, vol. 7, pp. 69–70, 2012. View at Google Scholar
  30. H. Qunyan, “Clinical observation on 32 cases of dilated cardiomyopathy treated with combination of traditional Chinese and Western Medicine,” Chinese Folk Medicine, no. 9, pp. 94–96, 2012. View at Google Scholar
  31. G. Jinliang, Z. Lihong, and Y. Yuheng, “Combination of traditional Chinese medicine and western medicine in the treatment of dilated cardiomyopathy and heart failure: observation of 30 cases,” Tianjin Traditional Chinese Medicine, vol. 4, pp. 291–292, 2011. View at Google Scholar
  32. Organizing Committee of the Chinese Symposium on Myocardium and Cardiomyopathy, “Summary of the Symposium on myocarditis and cardiomyopathy in China,” Journal of Clinical Cardiology, vol. 11, pp. 324–326, 1995. View at Google Scholar
  33. Member of Editorial Committee of Chinese Journal of cardiovascular diseases, “Summary of the Symposium on myocarditis and cardiomyopathy in China,” Chinese Journal of Cardiovascular Diseases, vol. 27, pp. 408–412, 1999. View at Google Scholar
  34. M. Wenzhu and Z. Jinan, Myocardial Disease, Jiangsu Science and Technology Press, Nanjing, China, 2001.
  35. Y. Rengao and L. Zaiying, Internal Medicine, vol. 159, People's Medical Publishing House, Beijing, China, 6th edition, 2004.
  36. L. Zaiying and Z. Nanshan, Internal Medicine, People's Medical Publishing House, Beijing, China, 7th edition, 2012.
  37. C. Haozhu, Practical Department of Internal Medicine, vol. 9th, People's Medical Publishing House, Beijing, China, 1993.
  38. Editorial Board of Practical Department of Internal Medicine. Shanghai Medical University, Practical Department of Internal Medicine, People's Medical Publishing House, Beijing, China, 8th edition, 1986.
  39. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, The Cochrane Collaboration, Oxford, UK, 2011, http://handbook.cochrane.org/.
  40. M. Borenstein, L. V. Hedges, J. P. T. Higgins, and H. R. Rothstein, “Part 3: fixed-effect versus random-effects models,” in Introduction to Meta-Analysis, pp. 61–102, John Wiley & Sons, West Sussex, UK, 2009. View at Google Scholar
  41. C. S. Rihal, R. A. Nishimura, L. K. Hatle, K. R. Bailey, and A. J. Tajik, “Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis,” Circulation, vol. 90, no. 6, pp. 2772–2779, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Yanwen and Z. Jinzhi, “Effect of Astragalus on viral heart disease,” Journal of Clinical Cardiovascular Diseases, vol. 16, no. 7, pp. 330–331, 2000. View at Google Scholar
  43. G. H. Gyatt, M. J. Sullivan, P. J. Thompson et al., “The 6-minute walk test: a new measure of exercise capacity in patients with chronic heart failure,” Canadian Medical Association Journal, vol. 132, pp. 919–923, 1985. View at Google Scholar
  44. W. C. Levy, D. Mozaffarian, D. T. Linker et al., “The Seattle Heart Failure Model: prediction of survival in heart failure,” Circulation, vol. 113, no. 11, pp. 1424–1433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Yang, “Effect of Compound Danshen Injection on plasma CGRP and ET levels in patients with coronary heart disease complicated with congestive heart failure,” Chinese Journal of Integrated Traditional Chinese and Western Medicine, vol. 17, no. 2, p. 96, 2001. View at Google Scholar
  46. H. Ling and C. Keji, “Advances in experimental pharmacology of Astragalus on cardiovascular system,” Chinese Journal of Integrated Traditional Chinese and Western Medicine, vol. 20, no. 3, pp. 234–237, 2000. View at Google Scholar
  47. L. Xiaoyan and W. Qinan, “Treatment of 48 cases of senile chronic heart failure with strong heart capsule,” Journal of Cardiovascular and Cerebrovascular Diseases, vol. 10, no. 5, pp. 522–523, 2012. View at Google Scholar
  48. M. Faguang and Z. Yiqin, “Clinical study of Ge Gensu on BNP level in patients with chronic heart failure,” Jilin Traditional Chinese Medicine, vol. 26, no. 12, pp. 17–18, 2006. View at Google Scholar
  49. W. Benxiang, Modern Pharmacology of Traditional Chinese Medicine, Tianjin Science and Technology Press, Tianjin, China, 1997.
  50. S. Yingjun, Pharmacology of Traditional Chinese Medicine, People's Medical Publishing House, Beijing, China, 2000.
  51. F. Hangyu and L. Ganzhong, “Ten years progress in the research of pharmacology of Chinese Materia Medica,” Chinese Pharmacological Bulletin, vol. 12, no. 3, pp. 201–206, 1996. View at Google Scholar
  52. T. Yuansheng and D. Shengming, “Discussion on the treatment of dilated cardiomyopathy,” Journal of Traditional Chinese Medicine, vol. 44, no. 10, p. 784, 2003. View at Google Scholar
  53. G. Ge, Modern Practical Health Statistics, Soochow University Press, Suzhou, China, 2010.